nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Influenza like illness—Pentoxifylline—systemic scleroderma	0.0219	0.0219	CcSEcCtD
Terconazole—Dysmenorrhoea—Mometasone—systemic scleroderma	0.0214	0.0214	CcSEcCtD
Terconazole—Influenza like illness—Mometasone—systemic scleroderma	0.0189	0.0189	CcSEcCtD
Terconazole—Bronchospasm—Pentoxifylline—systemic scleroderma	0.0139	0.0139	CcSEcCtD
Terconazole—Influenza like illness—Mycophenolic acid—systemic scleroderma	0.013	0.013	CcSEcCtD
Terconazole—Bronchospasm—Mometasone—systemic scleroderma	0.012	0.012	CcSEcCtD
Terconazole—Influenza like illness—Lisinopril—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Terconazole—Bronchospasm—Captopril—systemic scleroderma	0.0105	0.0105	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.00974	0.00974	CcSEcCtD
Terconazole—Face oedema—Mycophenolic acid—systemic scleroderma	0.00941	0.00941	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.0092	0.0092	CcSEcCtD
Terconazole—Ill-defined disorder—Pentoxifylline—systemic scleroderma	0.00914	0.00914	CcSEcCtD
Terconazole—Malaise—Pentoxifylline—systemic scleroderma	0.00888	0.00888	CcSEcCtD
Terconazole—Face oedema—Lisinopril—systemic scleroderma	0.00847	0.00847	CcSEcCtD
Terconazole—Myalgia—Pentoxifylline—systemic scleroderma	0.00839	0.00839	CcSEcCtD
Terconazole—Discomfort—Pentoxifylline—systemic scleroderma	0.00828	0.00828	CcSEcCtD
Terconazole—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00804	0.00804	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.0079	0.0079	CcSEcCtD
Terconazole—Bronchospasm—Lisinopril—systemic scleroderma	0.00746	0.00746	CcSEcCtD
Terconazole—Face oedema—Mycophenolate mofetil—systemic scleroderma	0.00742	0.00742	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00732	0.00732	CcSEcCtD
Terconazole—Arthralgia—Mometasone—systemic scleroderma	0.00724	0.00724	CcSEcCtD
Terconazole—Myalgia—Mometasone—systemic scleroderma	0.00724	0.00724	CcSEcCtD
Terconazole—Anaphylactic shock—Mometasone—systemic scleroderma	0.00694	0.00694	CcSEcCtD
Terconazole—Ill-defined disorder—Captopril—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Terconazole—Malaise—Captopril—systemic scleroderma	0.00673	0.00673	CcSEcCtD
Terconazole—Chills—Azathioprine—systemic scleroderma	0.00671	0.00671	CcSEcCtD
Terconazole—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00662	0.00662	CcSEcCtD
Terconazole—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00657	0.00657	CcSEcCtD
Terconazole—Urticaria—Pentoxifylline—systemic scleroderma	0.00639	0.00639	CcSEcCtD
Terconazole—Myalgia—Captopril—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Terconazole—Arthralgia—Captopril—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Terconazole—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Terconazole—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Terconazole—Chills—Leflunomide—systemic scleroderma	0.00634	0.00634	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00632	0.00632	CcSEcCtD
Terconazole—Discomfort—Captopril—systemic scleroderma	0.00628	0.00628	CcSEcCtD
Terconazole—Anaphylactic shock—Captopril—systemic scleroderma	0.00609	0.00609	CcSEcCtD
Terconazole—Chills—Mycophenolic acid—systemic scleroderma	0.00605	0.00605	CcSEcCtD
Terconazole—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00604	0.00604	CcSEcCtD
Terconazole—Pain—Mometasone—systemic scleroderma	0.00593	0.00593	CcSEcCtD
Terconazole—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00592	0.00592	CcSEcCtD
Terconazole—Malaise—Azathioprine—systemic scleroderma	0.00587	0.00587	CcSEcCtD
Terconazole—Asthenia—Pentoxifylline—systemic scleroderma	0.00577	0.00577	CcSEcCtD
Terconazole—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00571	0.00571	CcSEcCtD
Terconazole—Pruritus—Pentoxifylline—systemic scleroderma	0.00569	0.00569	CcSEcCtD
Terconazole—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00567	0.00567	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00555	0.00555	CcSEcCtD
Terconazole—Malaise—Leflunomide—systemic scleroderma	0.00555	0.00555	CcSEcCtD
Terconazole—Arthralgia—Azathioprine—systemic scleroderma	0.00555	0.00555	CcSEcCtD
Terconazole—Myalgia—Azathioprine—systemic scleroderma	0.00555	0.00555	CcSEcCtD
Terconazole—Abdominal pain—Mometasone—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Terconazole—Body temperature increased—Mometasone—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Terconazole—Discomfort—Azathioprine—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Terconazole—Chills—Lisinopril—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Terconazole—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Terconazole—Dizziness—Pentoxifylline—systemic scleroderma	0.00532	0.00532	CcSEcCtD
Terconazole—Malaise—Mycophenolic acid—systemic scleroderma	0.00529	0.00529	CcSEcCtD
Terconazole—Myalgia—Leflunomide—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Terconazole—Arthralgia—Leflunomide—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Terconazole—Discomfort—Leflunomide—systemic scleroderma	0.00517	0.00517	CcSEcCtD
Terconazole—Vomiting—Pentoxifylline—systemic scleroderma	0.00511	0.00511	CcSEcCtD
Terconazole—Rash—Pentoxifylline—systemic scleroderma	0.00507	0.00507	CcSEcCtD
Terconazole—Dermatitis—Pentoxifylline—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Terconazole—Headache—Pentoxifylline—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Terconazole—Face oedema—Prednisone—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Terconazole—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Terconazole—Feeling abnormal—Captopril—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Terconazole—Arthralgia—Mycophenolic acid—systemic scleroderma	0.005	0.005	CcSEcCtD
Terconazole—Myalgia—Mycophenolic acid—systemic scleroderma	0.005	0.005	CcSEcCtD
Terconazole—Gastrointestinal pain—Captopril—systemic scleroderma	0.00498	0.00498	CcSEcCtD
Terconazole—Asthenia—Mometasone—systemic scleroderma	0.00498	0.00498	CcSEcCtD
Terconazole—Discomfort—Mycophenolic acid—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Terconazole—Pruritus—Mometasone—systemic scleroderma	0.00491	0.00491	CcSEcCtD
Terconazole—Ill-defined disorder—Lisinopril—systemic scleroderma	0.0049	0.0049	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Terconazole—Abdominal pain—Captopril—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Terconazole—Body temperature increased—Captopril—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Terconazole—Nausea—Pentoxifylline—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Terconazole—Chills—Mycophenolate mofetil—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Terconazole—Malaise—Lisinopril—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Terconazole—Arthralgia—Lisinopril—systemic scleroderma	0.0045	0.0045	CcSEcCtD
Terconazole—Myalgia—Lisinopril—systemic scleroderma	0.0045	0.0045	CcSEcCtD
Terconazole—Discomfort—Lisinopril—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Terconazole—Vomiting—Mometasone—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Terconazole—Feeling abnormal—Azathioprine—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Terconazole—Rash—Mometasone—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Terconazole—Asthenia—Captopril—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Terconazole—Dermatitis—Mometasone—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Terconazole—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Terconazole—Headache—Mometasone—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Terconazole—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Terconazole—Pruritus—Captopril—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Terconazole—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Terconazole—Pain—Leflunomide—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Terconazole—Body temperature increased—Azathioprine—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Terconazole—Abdominal pain—Azathioprine—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Terconazole—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00418	0.00418	CcSEcCtD
Terconazole—Feeling abnormal—Leflunomide—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Terconazole—Nausea—Mometasone—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Terconazole—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00411	0.00411	CcSEcCtD
Terconazole—Pain—Mycophenolic acid—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Terconazole—Dizziness—Captopril—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Terconazole—Urticaria—Leflunomide—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Terconazole—Body temperature increased—Leflunomide—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Terconazole—Abdominal pain—Leflunomide—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Terconazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Terconazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Terconazole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Terconazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Terconazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Terconazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Terconazole—Vomiting—Captopril—systemic scleroderma	0.00387	0.00387	CcSEcCtD
Terconazole—Rash—Captopril—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Terconazole—Dermatitis—Captopril—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Terconazole—Headache—Captopril—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Terconazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Terconazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Terconazole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Terconazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Terconazole—Pain—Lisinopril—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Terconazole—Nausea—Captopril—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Terconazole—Asthenia—Leflunomide—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Terconazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Terconazole—Pruritus—Leflunomide—systemic scleroderma	0.00355	0.00355	CcSEcCtD
Terconazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Terconazole—Dizziness—Azathioprine—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Terconazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Terconazole—Urticaria—Lisinopril—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Terconazole—Abdominal pain—Lisinopril—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Terconazole—Body temperature increased—Lisinopril—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Terconazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Terconazole—Vomiting—Azathioprine—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Terconazole—Rash—Azathioprine—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Terconazole—Dermatitis—Azathioprine—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Terconazole—Headache—Azathioprine—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Terconazole—Dizziness—Leflunomide—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Terconazole—Pain—Mycophenolate mofetil—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Terconazole—Vomiting—Leflunomide—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Terconazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Terconazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Terconazole—Rash—Leflunomide—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Terconazole—Dermatitis—Leflunomide—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Terconazole—Nausea—Azathioprine—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Terconazole—Headache—Leflunomide—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Terconazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Terconazole—Asthenia—Lisinopril—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Terconazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Terconazole—Pruritus—Lisinopril—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Terconazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Terconazole—Rash—Mycophenolic acid—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Terconazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Terconazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.003	0.003	CcSEcCtD
Terconazole—Headache—Mycophenolic acid—systemic scleroderma	0.003	0.003	CcSEcCtD
Terconazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Terconazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Terconazole—Nausea—Leflunomide—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Terconazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Terconazole—Dizziness—Lisinopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Terconazole—Nausea—Mycophenolic acid—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Terconazole—Malaise—Prednisone—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Terconazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Terconazole—Vomiting—Lisinopril—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Terconazole—Rash—Lisinopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Terconazole—Dermatitis—Lisinopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Terconazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Terconazole—Chills—Methotrexate—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Terconazole—Headache—Lisinopril—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Terconazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Terconazole—Arthralgia—Prednisone—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Terconazole—Myalgia—Prednisone—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Terconazole—Discomfort—Prednisone—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Terconazole—Nausea—Lisinopril—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Terconazole—Anaphylactic shock—Prednisone—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Terconazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Terconazole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Terconazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Terconazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Terconazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Terconazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Terconazole—Malaise—Methotrexate—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Terconazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Terconazole—Myalgia—Methotrexate—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Terconazole—Arthralgia—Methotrexate—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Terconazole—Discomfort—Methotrexate—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Terconazole—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Terconazole—Feeling abnormal—Prednisone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Terconazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Terconazole—Urticaria—Prednisone—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Terconazole—Abdominal pain—Prednisone—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Terconazole—Body temperature increased—Prednisone—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Terconazole—Hypersensitivity—Prednisone—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Terconazole—Asthenia—Prednisone—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Terconazole—Pain—Methotrexate—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Terconazole—Pruritus—Prednisone—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Terconazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Terconazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Terconazole—Urticaria—Methotrexate—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Terconazole—Dizziness—Prednisone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Terconazole—Abdominal pain—Methotrexate—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Terconazole—Body temperature increased—Methotrexate—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Terconazole—Vomiting—Prednisone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Terconazole—Rash—Prednisone—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Terconazole—Dermatitis—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Terconazole—Headache—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Terconazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Terconazole—Asthenia—Methotrexate—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Terconazole—Nausea—Prednisone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Terconazole—Pruritus—Methotrexate—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Terconazole—Dizziness—Methotrexate—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Terconazole—Vomiting—Methotrexate—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Terconazole—Rash—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Terconazole—Dermatitis—Methotrexate—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Terconazole—Headache—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Terconazole—Nausea—Methotrexate—systemic scleroderma	0.00127	0.00127	CcSEcCtD
